Literature DB >> 12050231

Genetic analysis of Japanese patients with 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21.

Satomi Koyama1, Takio Toyoura, Sumitaka Saisho, Kazuhiko Shimozawa, Junichi Yata.   

Abstract

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is one of the most common inherited metabolic diseases. We studied 52 Japanese 21-hydroxylase deficiency patients corresponding to 49 families (98 chromosomes) to detect the mutations in 21-hydroxylase genes using Southern blotting, PCR-restriction fragment length polymorphism, and a direct sequencing method. Among the 52 patients (49 families), 35 patients (33 families) were diagnosed as the salt-wasting type, 12 (12 families) as the simple virilizing type, and 5 (4 families) as the nonclassical type. Our findings were as follows. 1) The complete genotype that had homozygous or compound heterozygous mutations was determined in 43 of 49 families (87.8%). Among the remaining patients, no mutation was found in the structural gene of either allele in 3 cases, and a mutation was detected in only 1 allele in 3 cases. This means that at least 9 of 98 alleles have some unusual mutations or recombinations that we cannot detect by our method or gene defects outside of the structural gene. 2) Although the common mutation of Caucasian nonclassical patients is V281L, none of our 4 nonclassical families showed this mutation, and 3 of them had the P30L mutation at least on 1 allele. 3) We identified a putative new mutation, homozygous deletion of adenine at codon 246, in a salt-wasting patient. Although we have not analyzed the functional consequence of this mutation, it causes substitution noncoding for Met(256) in exon 7 and premature termination of the mRNA before the heme-binding region of the P450 polypeptide, which would result in a completely nonfunctional enzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050231     DOI: 10.1210/jcem.87.6.8522

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia.

Authors:  P Balraj; P G Lim; H Sidek; L L Wu; A S B Khoo
Journal:  J Endocrinol Invest       Date:  2012-10-01       Impact factor: 4.256

2.  Molecular diagnosis of Chinese patients with 21-hydroxylase deficiency and analysis of genotype-phenotype correlations.

Authors:  Bo Zhang; Lin Lu; Zhaolin Lu
Journal:  J Int Med Res       Date:  2017-02-02       Impact factor: 1.671

3.  Clinical profile and inheritance pattern of CYP21A2 gene mutations in patients with classical congenital adrenal hyperplasia from 10 families.

Authors:  Sarita Yadav; Shweta Birla; Eunice Marumudi; Arundhati Sharma; Rajesh Khadgawat; M L Khurana; A C Ammini
Journal:  Indian J Endocrinol Metab       Date:  2015 Sep-Oct

4.  In Vitro Enzyme Assay of CYP21A2 Mutation (R483Q) by A Novel Method Using Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS).

Authors:  Makoto Ono; Kenichi Kashimada; Kentaro Miyai; Toshikazu Onishi; Masatoshi Takagi; Seijiro Honma; Shuki Mizutani
Journal:  Clin Pediatr Endocrinol       Date:  2008-05-08

5.  Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision).

Authors:  Tomohiro Ishii; Makoto Anzo; Masanori Adachi; Kazumichi Onigata; Satoshi Kusuda; Keisuke Nagasaki; Shohei Harada; Reiko Horikawa; Masanori Minagawa; Kanshi Minamitani; Haruo Mizuno; Yuji Yamakami; Masaru Fukushi; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2015-07-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.